Vibe GrowthFRA:3ST0 +0.43%29 Gross Margin % is 42.91% as of Mar. 2026, which is 17% above its 10-year median of 36.56. GuruFocus rates FRA:3ST0 with a GF Score™ of 29/100 and a GF Value™ of €0.08 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 938 Drug Manufacturers companies, Vibe Growth ranks worse than 59.06% on this metric.
The historical rank and industry rank for Vibe Growth's Gross Margin % or its related term are showing as below:
FRA:3ST0'
s Gross Margin % Range Over the Past 10 Years
Min: 28.76 Med: 36.56 Max: 44.48
Current: 43.2
During the past 13 years, the highestGross Margin % of Vibe Growth was 44.48%. The lowest was 28.76%. And the median was 36.56%.
FRA:3ST0's Gross Margin % is ranked worse than 59.06% of 938
companies
in the Drug Manufacturers industry
Industry Median: 48.44
vs FRA:3ST0: 43.20
Vibe Growth had a gross margin of 42.91% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Vibe Growth was 6.20% per year.
Vibe Growth (FRA:3ST0) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Vibe Growth had a gross margin of 42.91% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Vibe Growth Gross Margin % Related Terms
Vibe Growth Gross Margin % Historical Data
* Premium members only.
The historical data trend for Vibe Growth's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Vibe Growth's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vibe Growth Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Vibe Growth's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Vibe Growth's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Vibe Growth (FRA:3ST0) has a Gross Margin % of 42.91% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Vibe Growth and its competitors. This is 17% above median its historical median of 36.56. Over the past decade, Vibe Growth's Gross Margin % has ranged from 28.76 to 44.48. According to the industry distribution chart, Vibe Growth ranks #554 out of 938 companies in the Drug Manufacturers industry, placing it in the top 59.1%.
Is Vibe Growth's Gross Margin % too high?
Vibe Growth's current Gross Margin % of 42.91% is 17% above median its 10-year median of 36.56. Over the past 10 years, this metric has ranged from a low of 28.76 to a high of 44.48. The Drug Manufacturers industry median Gross Margin % is 48.44. Vibe Growth's value of 42.91% is 11.4% below this industry median. Based on the distribution chart, Vibe Growth ranks #554 out of 938 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Vibe Growth has a GF Score™ of 29/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Vibe Growth's Gross Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Vibe Growth ranks #554 out of 938 companies for Gross Margin %. This places Vibe Growth in the lower half of its industry. The industry median Gross Margin % is 48.44. Vibe Growth's value of 42.91% is 11.4% below this benchmark. Historically, Vibe Growth's own Gross Margin % has ranged from 28.76 to 44.48 over the past decade. While the company's 10-year median is 36.56 vs. the industry median of 48.44, Vibe Growth has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.44, based on 938 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vibe Growth's current Gross Margin % of 42.91% is 11.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Vibe Growth and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vibe Growth's current Gross Margin % is 42.91%, which is 17% above median its own 10-year median of 36.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vibe Growth stock overvalued right now?
Based on GuruFocus' analysis, Vibe Growth (FRA:3ST0) is currently considered Significantly Overvalued. The stock's GF Value™ is €0.08, compared to a current price of €0.23 — trading 191.3% above its estimated fair value. The current Gross Margin % is 42.91%, which is 17% above median its 10-year median of 36.56 and 11.4% below the Drug Manufacturers industry median of 48.44. Vibe Growth's overall GF Score™ is 29/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Vibe Growth (FRA:3ST0), the current Gross Margin % is 42.91% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Vibe Growth (FRA:3ST0) Overvalued in 2026?
Based on GuruFocus' analysis, Vibe Growth stock appears to be overvalued.
The current stock price of €0.23 is trading 191.3% above its estimated GF Value™ of €0.08.
GuruFocus considers Vibe Growth to be Significantly Overvalued.
Key valuation signals for FRA:3ST0:
Gross Margin %: 42.91% (17% above median its 10-year median of 36.56)
GF Value™: €0.08 vs. price of €0.23 (191.3% above fair value)
Industry Position: 11.4% below the Drug Manufacturers median (#554 of 938)
No single metric tells the full story. See the FRA:3ST0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Vibe Growth Corp is engaged in the evaluation, acquisition, and development of cannabis cultivation, distribution, and manufacturing assets and retail cannabis dispensaries, predominantly in the U.S., to become a vertically integrated cannabis operator. The company currently operates four dispensaries, one distribution, and one cultivation operation in the State of California, plus one dispensary in Portland, Oregon. It offers cannabis infused products across various categories such as vaporizers, concentrates, edibles, topicals, pre-rolls, etc., and through different brands including Alien Labs, Almora Farm, Buddies, Chill Bud, Highatus, and Others.
29GF Score
Get the complete analysis for FRA:3ST0
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:3ST0 has been successfully added to your 
